Needham & Company LLC Issues Positive Forecast for Cognex (NASDAQ:CGNX) Stock Price

Key Points

• Needham & Company raised its price target on Cognex from $67 to $75 and kept a "buy" rating — the upgrade implies roughly a 13.4% upside, while the Street consensus is a Moderate Buy with an average target of $62.29.
• Strong Q1 report and upbeat guidance: Cognex posted revenue of $268.4M (+24.3% YoY) and EPS $0.34, beating estimates, and guided Q2 to $280–$300M revenue with EPS $0.40–$0.44, signaling continued growth and margin leverage.
• Insider selling and ownership mix: Insiders sold ~196,083 shares (~$11.4M) over the past three months (insiders now own 1.7%), while hedge funds/institutions hold ~88% of the stock, a dynamic that could influence sentiment despite the positive results.

Cognex (NASDAQ:CGNX - Get Free Report) had its price objective raised by Needham & Company LLC from $67.00 to $75.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a "buy" rating on the scientific and technical instruments company's stock. Needham & Company LLC's target price would indicate a potential upside of 13.42% from the company's current price.

A number of other research analysts have also issued reports on CGNX. UBS Group restated a "buy" rating and set a $70.00 price target on shares of Cognex in a research note on Friday, February 13th. Barclays increased their price target on shares of Cognex from $61.00 to $64.00 and gave the stock an "overweight" rating in a report on Monday, March 16th. Raymond James Financial reissued a "strong-buy" rating on shares of Cognex in a report on Thursday, February 12th. Truist Financial lowered their price target on shares of Cognex from $52.00 to $50.00 and set a "hold" rating on the stock in a report on Monday, April 20th. Finally, DA Davidson set a $55.00 price target on shares of Cognex and gave the stock a "neutral" rating in a report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the company's stock. According to MarketBeat, Cognex has a consensus rating of "Moderate Buy" and an average price target of $62.29.

Cognex Stock Up 6.2%

NASDAQ CGNX opened at $66.13 on Friday. The firm has a market cap of $11.04 billion, a PE ratio of 78.72 and a beta of 1.48. The company has a 50 day moving average price of $52.67 and a 200 day moving average price of $45.20. Cognex has a 52 week low of $28.56 and a 52 week high of $71.90.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.86%. The business had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. During the same quarter in the prior year, the business posted $0.14 EPS. Cognex's revenue for the quarter was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, equities research analysts anticipate that Cognex will post 0.97 earnings per share for the current fiscal year.

Insider Transactions at Cognex

In other news, VP Laura Ann Macdonald sold 14,881 shares of the firm's stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $57.16, for a total value of $850,597.96. Following the transaction, the vice president directly owned 2,212 shares of the company's stock, valued at approximately $126,437.92. This trade represents a 87.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Angelos Papadimitriou sold 4,150 shares of the firm's stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $55.58, for a total transaction of $230,657.00. Following the completion of the transaction, the director directly owned 16,222 shares in the company, valued at approximately $901,618.76. This represents a 20.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 196,083 shares of company stock valued at $11,419,321. Corporate insiders own 1.70% of the company's stock.

Hedge Funds Weigh In On Cognex

A number of institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in Cognex by 2.1% during the third quarter. Vanguard Group Inc. now owns 18,598,728 shares of the scientific and technical instruments company's stock worth $842,522,000 after purchasing an additional 374,999 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in Cognex by 173,138.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company's stock worth $376,979,000 after purchasing an additional 10,471,400 shares during the period. Nordea Investment Management AB raised its stake in Cognex by 0.9% during the fourth quarter. Nordea Investment Management AB now owns 8,101,583 shares of the scientific and technical instruments company's stock worth $292,224,000 after purchasing an additional 76,212 shares during the period. Pictet Asset Management Holding SA raised its stake in Cognex by 27.9% during the fourth quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company's stock worth $252,360,000 after purchasing an additional 1,529,010 shares during the period. Finally, Price T Rowe Associates Inc. MD raised its stake in Cognex by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company's stock worth $191,231,000 after purchasing an additional 1,258,629 shares during the period. 88.12% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q1 results and upbeat Q2 guide — Cognex reported revenue of $268M (+24% YoY) and EPS $0.34, topping estimates, and issued Q2 revenue guidance of $280–$300M with EPS $0.40–$0.44, signaling continued growth and margin leverage. Cognex Reports First Quarter 2026 Results
• Positive Sentiment: Margin and profitability beat — gross margin expanded to ~71% and adjusted EBITDA margin improved materially, underscoring operating leverage that supports higher EPS power. Cognex Q1 Earnings and Revenues Top Estimates
• Positive Sentiment: AI product momentum highlighted on the call — management emphasized AI-led vision product launches and demand across broad end markets, which investors view as a durable growth driver. Cognex Earnings Call Highlights AI-Led Profit Surge
• Positive Sentiment: Analyst price-target upgrade — Stephens raised its price target to $75 and moved to overweight, giving formal Street support that can drive buy-side flows. Cognex Given New $75.00 Price Target at Stephens
• Positive Sentiment: Unusually heavy call activity — a large block of call option volume suggests short-term bullish positioning by traders/speculators ahead of/after the results. Cognex Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Dividend announced — Cognex declared a $0.085 quarterly dividend (annualized ~0.5% yield), a modest income signal but not a material catalyst for stock rerating. Listen to Conference Call / Press Release
• Neutral Sentiment: Market commentary and stock momentum pieces question valuation after a big run — some articles debate whether further upside is warranted after substantial YTD/one‑year gains; useful for investor context but not new company data. Is It Too Late To Consider Cognex (CGNX) After A 121% One Year Surge?
• Negative Sentiment: Recent insider selling and some institutional repositioning — public filings referenced notable insider sales and large portfolio moves that could weigh on sentiment if sustained. Cognex shares jump on Q1 beat and upbeat Q2 outlook

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.